nach oben

Journal of Neurology

Erschienen in:

01.08.2012 | Original Article

Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for multiple sclerosis from the perspective of physicians

verfasst von: Stephanie Berno, Michaela Coenen, Andreas Leib, Alarcos Cieza, Jürg Kesselring

Erschienen in: Journal of Neurology | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

The Comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for multiple sclerosis (MS) is an application of the ICF to describe the typical spectrum of functioning in people with MS. The objective of this study was to validate the Comprehensive ICF Core Set for MS from the perspective of physicians. Using a three-round Delphi technique, physicians experienced in the MS treatment were requested to name patients’ problems, resources, and aspects of environment. The statements of the first Delphi round were linked to ICF categories based on established linking rules. These categories as well as the results of the second round were reported back to the participants. Eighty-four physicians participated in the study. Totally, 89 categories (64.5%) of the Comprehensive ICF Core Set for MS were confirmed by the participants. Eight ICF categories, which are currently not included in the ICF Core Set, were identified. The validity of the Comprehensive ICF Core Set for MS was largely affirmed by the physicians. However, some additional categories were named, which should be further discussed regarding a revised version of the Comprehensive ICF Core Set for MS.

The National Collaborating Centre for Chronic Conditions (2004) Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care. Royal College of Physicians of London, London

Stevenson VL, Playford ED (2007) Rehabilitation and MS. Int MS J 14:85–92PubMed

Foley JF, Brandes DW (2009) Redefining functionality and treatment efficacy in multiple sclerosis. Neurology 72:S1–S11PubMedCrossRef

Thompson AJ (1999) Measuring handicap in multiple sclerosis. Mult Scler 5:260–262PubMed

Rasova K, Feys P, Henze T, van Tongeren H, Cattaneo D, Jonsdottir et al (2010) Emerging evidence-based physical rehabilitation for multiple sclerosis—towards an inventory of current content across Europe. Health Qual Life Outcomes 8. doi: 10.1186/14777525876

World Health Organization (WHO) (2001) International classification of functioning, disability and health ICF. World Health Organization, Geneva

Stucki G (2004) Applying the ICF in medicine. J Rehabil Med Suppl 44:5–6CrossRef

Cieza A, Ewert T, Üstün B, Chatterji S, Kostanjsek N, Stucki G (2004) Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med Suppl 44:9–11

Coenen M, Cieza A, Freeman J, Khan F, Miller D, Weise A et al (2011) The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference. J Neurol 258:1477–1488PubMedCrossRef

10.

Holper L, Coenen M, Andrea W, Stucki G, Cieza A, Kesselring J (2010) Characterization of functioning in multiple sclerosis using the ICF. J Neurol 257:103–113PubMedCrossRef

11.

Rauch A, Cieza A, Stucki G (2008) How to apply the International Classification of Functioning, Disability and Health (ICF) for rehabilitation management in clinical practice. Eur J Phys Rehabil Med 44:329–342PubMed

12.

Linstone HA, Turoff M, Helmer O (1975) The Delphi method. Techniques and applications. Addison-Wesley, Reading, MA

13.

Hasson F, Keeney S, McKenna H (2000) Research guidelines for the Delphi survey technique. J Adv Nurs 32:1008–1015PubMed

14.

Jones J, Hunter D (1995) Consensus methods for medical and health services research. Br Med J 311:376–380CrossRef

15.

Hsu C, Sandford BA (2007) The Delphi technique: making sense of consensus. PARE 10:1–8

16.

Cieza A, Brockow T, Ewert T, Amann E, Kollerits B, Chatterji S (2002) Linking health-status measurements to the International Classification of Functioning, Disability and Health. J Rehabil Med 34:205–210PubMedCrossRef

17.

Cieza A, Geyh S, Chatterji S, Kostanjsek N, Üstün B, Stucki G (2005) ICF linking rules: an update based on lessons learned. J Rehabil Med 37:212–218

18.

Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20:37–46CrossRef

19.

Vierkant RA (2009) A SAS^® Macro for calculating bootstrapped confidence intervals about a kappa coefficient. http://www2.sas.com/proceedings/sugi22/STATS/PAPER295.PDF. Accessed March 2009

20.

Sundström P, Svenningsson A, Nyström L, Forsgren L (2004) Clinical characteristics of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry 75:711–716PubMedCrossRef

21.

Frohman EM, Zhang H, Dewey RB, Hawker KS, Racke MK, Frohman TC (2000) Vertigo in MS: utility of positional and particle repositioning maneuvers. Neurology 55:1566–1569PubMedCrossRef

22.

Sanders EA, Arts RJ (1986) Paraesthesiae in multiple sclerosis. J Neurol Sci 74:297–305PubMedCrossRef

23.

Beiske AG, Pedersena ED, Czujkob BMK (2004) Pain and sensory complaints in multiple sclerosis. Eur J Neurol 11:479–482PubMedCrossRef

24.

Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–691PubMedCrossRef

25.

McIntosh-Michaelis SA, Roberts MH, Wilkinson SM, Diamond ID, McLellan DL, Martin JP et al (1991) The prevalence of cognitive impairment in a community survey of multiple sclerosis. Br J Clin Psychol 30:333–348PubMedCrossRef

26.

Amato MP, Zipoli V, Portaccio E (2006) Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 245:41–46PubMedCrossRef

27.

Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283–288PubMedCrossRef

28.

Simionit S, Ruffieux C, Bruggimann L, Annoni JM, Schluep M (2007) Cognition, mood and fatigue in patients in the early stage of multiple sclerosis. Swiss Med Wkly 137:496–501

29.

Cutajar R, Ferriani E, Scandellari C, Sabattini L, Trocino C, Marchello LP et al (2000) Cognitive function and quality of life in multiple sclerosis patients. J Neurovirol 6(Suppl 2):186–190

30.

Benito-Leon J, Morales JM, Riverra-Navarro J (2002) Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 9:497–502PubMedCrossRef

31.

Zivadinov R, Zorzon M, Bosco A, Monti Bragadin L, Moretti R, Bonfigli L et al (1999) Sexual dysfunction in multiple sclerosis: II. Correlation analysis. Mult Scler 5:428–431PubMed

32.

Richardson JP, Lazur A (1995) Sexuality in the nursing home patient. Am Fam Physician 51:121–124PubMed

33.

Gagliardi BA (2003) The experience of sexuality for individuals living with multiple sclerosis. J Clin Nurs 12:571–578PubMedCrossRef

34.

Sibley WA, Bamford CR, Clark K (1985) Clinical viral infections and multiple sclerosis. Lancet 1:1313–1315PubMedCrossRef

35.

D’hooghe MB, Nagels G, Bissay V, De Keyser J (2010) Modifiable factors influencing relapses and disability in multiple sclerosis. Mult Scler 167:773–785CrossRef

36.

Correale J, Fiol M, Gilmore W (2006) The risk of relapses in multiple sclerosis during systemic infections. Neurology 67:652–659PubMedCrossRef

37.

Buljevac D, Flach HZ, Hop WC, Hijdra D, Laman JD, Savelkoul H et al (2002) Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125:952–960PubMedCrossRef

38.

Metz LM, McGuinness SD, Harris C (1998) Urinary tract infections may trigger relapse in multiple sclerosis. Axone 19:67–70PubMed

39.

McCabe MP, McKern S, McDonald E (2004) Coping and psychological adjustment among people with multiple sclerosis. J Psychosom Res 56:355–356PubMedCrossRef

40.

Arnett PA, Higginson CI, Voss WD, Randolph JJ, Grandey AA (2002) Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clin Neuropsychol 16:341–355PubMedCrossRef

41.

Goretti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S et al (2009) Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci 30:15–20PubMedCrossRef

42.

Somerset M, Sharp D, Campbell R (2002) Multiple sclerosis and quality of life: a qualitative investigation. J Health Serv Res Policy 7:151–159PubMedCrossRef

43.

Box V, Hepworth M, Harrison J (2003) Identifying information needs of people with multiple sclerosis. Nurs Times 99:32–36PubMed

44.

Baker LM (1998) Sense making in multiple sclerosis: the information needs of people during an acute exacerbation. Qual Health Res 8:106–120PubMedCrossRef

45.

Johnson J (2003) On receiving the diagnosis of multiple sclerosis: managing the transition. Mult Scler 9:82–88PubMedCrossRef

46.

Lee M, O`Brian P (2008) Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 79:1308–1311PubMedCrossRef

47.

Race KE, Planek TW (1992) Modified scree test: further considerations on its application to Delphi study data. Eval Rev 16:171–183CrossRef

48.

Kostanjsek N, Rubinelli S, Escorpizo R, Cieza A, Kennedy C, Selb M et al (2011) Assessing the impact of health conditions using the ICF. Disabil Rehabil 33:1475–1482PubMedCrossRef

Titel: Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for multiple sclerosis from the perspective of physicians
verfasst von: Stephanie Berno
Michaela Coenen
Andreas Leib
Alarcos Cieza
Jürg Kesselring
Publikationsdatum: 01.08.2012
Verlag: Springer-Verlag
Erschienen in: Journal of Neurology / Ausgabe 8/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6399-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2012

Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy

Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert

Value of MRI as a surrogate marker for PML in natalizumab long-term therapy

Anti-aquaporin-4 antibody-positive recurrent isolated optic neuritis and primary Sjögren’s syndrome

Diagnostic yield and predictive value of provoked ictal SPECT in drug-resistant epilepsies

Towards understanding seasonal variability in cervical artery dissection (CeAD)